Hypothesis

The adrenal cortex ages through a mechanobiological shift: progressive extracellular matrix (ECM) stiffening in the pericapillary niche activates integrin‑β1/YAP signaling in stromal fibroblasts, which then secrete TGF‑β1 and impair mitochondrial biogenesis in adjacent zona reticularis cells, driving DHEA decline; concurrently, altered hepatic CYP3A4 activity reduces cortisol clearance, blunting the cortisol awakening response and flattening circadian rhythm.

Mechanistic rationale

1. ECM stiffening – Age‑related collagen cross‑linking increases tissue rigidity, a change documented in vascular rarefaction studies of the zona reticularis [https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2019.00054/full].
2. Integrin‑β1/YAP – Stiff ECM engages integrin‑β1, leading to nuclear translocation of YAP/TAZ in fibroblasts, a pathway known to drive profibrotic phenotypes.
3. Paracrine TGF‑β1 – Activated fibroblasts release TGF‑β1, which suppresses CYP17A1 transcription and mitochondrial oxidative phosphorylation in zona reticularis cells, directly lowering DHEA synthesis.
4. Cortisol clearance – Chronic low‑grade inflammation from fibroblast activation downregulates hepatic CYP3A4, decreasing cortisol metabolism and weakening HPA negative feedback, thereby attenuating the cortisol awakening response [https://pubmed.ncbi.nlm.nih.gov/22366337/]; [https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0152071].

Testable predictions

• In aged mice, pharmacological inhibition of lysyl oxidase (LOX) to reduce collagen cross‑linking will lower pericapillary ECM stiffness, decrease fibroblast YAP nuclear localization, and restore zona reticularis DHEA output to young adult levels.
• Conditional fibroblast‑specific knockout of integrin‑β1 will blunt TGF‑β1 elevation, preserve mitochondrial markers (e.g., COXIV, ATP5A) in zona reticularis, and increase circulating DHEA‑S without altering cortisol production.
• Administration of a TGF‑β1 neutralizing antibody will rescue CYP17A1 expression and mitochondrial respiration in isolated zona reticularis cultures from aged donors.
• Conversely, inducing hepatic CYP3A4 overexpression will accelerate cortisol clearance, steepen the morning cortisol rise, and improve CAR magnitude in aged subjects.

Experimental approach

• Animal model: Use 24‑month‑old C57BL/6 mice; treat groups with LOX inhibitor (β‑aminopropionitrile), fibroblast‑specific integrin‑β1 Cre‑loxP knockout, TGF‑β1 antibody, or AAV8‑CYP3A4 liver vector; include age‑matched controls.
• Readouts: Measure pericapillary collagen content (second harmonic generation imaging), fibroblast YAP localisation (immunofluorescence), zona reticularis CYP17A1 mRNA (qPCR), mitochondrial respiration (Seahorse), plasma DHEA‑S and cortisol (LC‑MS/MS), CAR via serial sampling after restraint stress.
• Human relevance: Correlate serum LOX levels and fibroblast‑derived TGF‑β1 in elderly participants with DHEA‑S/cortisol ratio and CAR from existing cohorts.

Falsifiability

If LOX inhibition fails to reduce ECM stiffness or does not raise DHEA‑S despite confirmed target engagement, or if fibroblast integrin‑β1 loss does not modify TGF‑β1 levels or zona reticularis function, the hypothesis would be refuted. Similarly, if hepatic CYP3A4 upregulation does not sharpen the cortisol awakening response, the clearance component would be invalidated.

This framework links vascular‑associated matrix mechanics to stromal fibroblast reprogramming, offering a reversible target to restore endogenous adrenal hormone youthfulness beyond simple DHEA replacement.